Search Within

Alumni (GSK)

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (91)
  2. Meeting Abstract (42)
  3. Research Letter (2)
  4. Review (2)
  5. Editorial (1)
Groups
  1. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (138)
  2. Molecular Pharmacology and Chemistry Program Faculty (138)
  3. Sloan Kettering Institute Faculty (138)
  4. GSK Faculty (134)
  5. Sloan Kettering Institute Postdocs (124)
  6. Department of Medicine (100)

More Groups

People
  1. Michel Sadelain (29)
  2. Ly Vu (22)
  3. Michael Kharas (22)
  4. Ross Levine (22)
  5. Anton Dobrin (19)
  6. Neal Rosen (18)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (9)
  4. 2022 (13)
  5. 2021 (15)
  6. 2020 (15)

More Years

Publications
  1. Blood (18)
  2. Cancer Research (16)
  3. Nature (9)
  4. Nature Communications (9)
  5. Cancer Discovery (8)
  6. Molecular Therapy (5)

More Publications

Publishers
  1. Nature Publishing Group (41)
  2. American Association for Cancer Research (29)
  3. American Society of Hematology (18)
  4. Cell Press (12)
  5. American Association for the Advancement of Science (4)
  6. American Chemical Society (3)

More Publishers

Results (138)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Engineered cells as a test platform for radiohaptens in pretargeted imaging and radioimmunotherapy applications
    Journal Article

    Dacek, M. M.; Veach, D. R.; Cheal, S. M.; Carter, L. M.; McDevitt, M. R.; Punzalan, B.; Burnes Vargas, D.; Kubik, T. Z.; Monette, S.; Santich, B. H.; more...
    Bioconjugate Chemistry (2021)

    Fulltext@MSK | Save
  • Anti-tumor effects of an ID antagonist with no observed acquired resistance
    Journal Article

    Wojnarowicz, P. M.; Garcia Escolano, M.; Huang, Y. H.; Desai, B.; Chin, Y.; Shah, R.; Xu, S.; Yadav, S.; Yaklichkin, S.; Ouerfelli, O.; more...
    npj Breast Cancer (2021)

    Fulltext@MSK | Save
  • CAR design and expression determine hyper-proliferative states in TET2 deficient T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Iyer, A.; Lopez, M.; Feucht, J.; Koche, R.; Yang, J.; Zhan, Y.; Sadelain, M.
    Molecular Therapy (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • CTLA-4 blockade drives loss of T(reg) stability in glycolysis-low tumours
    Journal Article

    Zappasodi, R.; Serganova, I.; Cohen, I. J.; Maeda, M.; Shindo, M.; Senbabaoglu, Y.; Watson, M. J.; Leftin, A.; Maniyar, R.; Verma, S.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis
    Journal Article

    Mukherjee, R.; Vanaja, K. G.; Boyer, J. A.; Gadal, S.; Solomon, H.; Chandarlapaty, S.; Levchenko, A.; Rosen, N.
    Molecular Cell (2021)

    Fulltext@MSK | Save
  • A self-assembling and disassembling (SADA) bispecific antibody (BsAb) platform for curative two-step pretargeted radioimmunotherapy
    Journal Article

    Santich, B. H.; Cheal, S. M.; Ahmed, M.; McDevitt, M. R.; Ouerfelli, O.; Yang, G.; Veach, D. R.; Fung, E. K.; Patel, M.; Burnes Vargas, D.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Loss of (TET2) uncouples proliferative and effector functions in CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Iyer, A. S.; Lopez, M.; Feucht, J.; Koche, R. P.; Zhan, Y.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis
    Meeting Abstract

    Mukherjee, R.; Vanaja, K. G.; Boyer, J. A.; Qiu, J.; Chen, X.; de Stanchina, E.; Chandarlapaty, S.; Levchenko, A.; Rosen, N.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CTLA-4 blockade promotes Treg glucose metabolism and reduces Treg functional stability in glycolysis-defective tumors
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Cohen, I.; Maeda, M.; Senbabaoglu, Y.; Shindo, M.; Maniyar, R.; Mane, M.; Leftin, A.; Watson, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save